Global population structure and evolution of Bordetella pertussis and their relationship with vaccination

mBio

Volumn 5, Issue 2, 2014, Pages

  Bart, Marieke J ^a,b   Harris, Simon R ^c   Advani, Abdolreza ^d   Arakawa, Yoshichika ^e   Bottero, Daniela ^f   Bouchez, Valérie ^g,h   Cassiday, Pamela K ⁱ   Chiang, Chuen Sheue ^j   Dalby, Tine ^k   Fry, Norman K ^l   Gaillard, María Emilia ^f   van Gent, Marjolein ^a   Guiso, Nicole ^g,h   Hallander, Hans O ^d   Harvill, Eric T ^m   He, Qiushui ⁿ   van der Heide, Han G J ^a   Heuvelman, Kees ^a   Hozbor, Daniela F ^f   Kamachi, Kazunari ^e   Karataev, Gennady I ^o   Lan, Ruiting ^p   Lutyńska, Anna ^q   Maharjan, Ram P ^p   Mertsola, Jussi ^r   Miyamura, Tatsuo ^e   Octavia, Sophie ^p   Preston, Andrew ^s   Quail, Michael A ^c   Sintchenko, Vitali ^t,u   Stefanelli, Paola ^v   Tondella, M Lucia ⁱ   Tsang, Raymond S W ^w   Xu, Yinghua ^x   Yao, Shu Man ^j   Zhang, Shumin ^x   Parkhill, Julian ^c   Mooi, Frits R ^a,b   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^g INSTITUT PASTEUR   (France)

^h CNRS   (France)

ⁱ NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^j CENTER FOR DISEASE CONTROL   (Taiwan)

^k STATENS SERUM INSTITUT   (Denmark)

^l PUBLIC HEALTH ENGLAND   (United Kingdom)

^m PENNSYLVANIA STATE UNIVERSITY   (United States)

ⁿ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^o N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^p UNIVERSITY OF NEW SOUTH WALES   (Australia)

^q NATIONAL INSTITUTE OF HYGIENE   (Poland)

^r TURKU UNIVERSITY HOSPITAL   (Finland)

^s University of Bath   (United Kingdom)

^t WESTMEAD HOSPITAL   (Australia)

^u UNIVERSITY OF SYDNEY   (Australia)

^v ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^w PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^x NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; BORDETELLA PERTUSSIS; EPIDEMIC; EUROPE; GENE LOCUS; GENETIC CODE; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERTUSSIS; PHYLOGENY; POPULATION STRUCTURE; PRIORITY JOURNAL; VACCINATION;

ADAPTATION, BIOLOGICAL; BORDETELLA PERTUSSIS; CLUSTER ANALYSIS; COMMUNICABLE DISEASES, EMERGING; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; HUMANS; INFANT; PERTUSSIS VACCINE; PHYLOGENY; VACCINATION; WHOOPING COUGH; WORLD HEALTH;

EID: 84899849406     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01074-14     Document Type: Article

References (81)

1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C, Child Health Epidemiology Reference Group of WHO and UNICEF. 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375:1969-1987. http://dx.doi.org/10.1016/ S0140-6736(10)60549-1.
2. Still GF. 1965. The history of paediatrics. Oxford University Press, London, United Kingdom.
3. Lapin JH. 1943. Whooping cough. Charles C. Thomas Publisher Ltd., Springfield, IL.
4. Magner LN. 1993. Diseases of the premodern period in Korea, p 392-400. In Kiple KF (ed), The Cambridge world history of human disease. Cambridge University Press, Cambridge, United Kingdom.
5. Mooi FR. 2010. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. Evol. 10:36-49. http:// dx.doi.org/10.1016/j.meegid.2009.10.007.
6. Spokes PJ, Quinn HE, McAnulty JM. 2010. Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. N. S. W. Public Health Bull. 21:167-173. http://dx.doi.org/10.1071/NB10031.
7. Health Protection Agency. 25 October 2012. Health protection report. Vol 6No 43. Health Protection Agency, London England. http://www.hpa. org.uk/hpr/archives/2012/hpr4312.pdf.
8. Conyn van Spaendock M, Van der Maas N, Mooi F. 2013. Control of whooping cough in the Netherlands: optimisation of the vaccination policy. RIVM letter report 215121002. National Institute for Public Health and the Environment, Bilthoven, The Netherlands. http://www.rivm.nl /bibliotheek/rapporten/215121002.pdf.
9. Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, Chavez G. 2012. California pertussis epidemic, 2010. J. Pediatr. 161: 1091-1096. http://dx.doi.org/10.1016/j.jpeds.2012.05.041.
10. DeBolt C, Tasslimi A, Bardi J, Leader B, Hiatt B, Quin X, Patel M, Martin S, Tondella ML, Cassiday P, Faulkner A, Messonnier NE, Clark TA, Meyer S. 2012. Pertussis epidemic-Washington, 2012. MMWR Morb. Mortal. Wkly. Rep. 61:517-522.
11. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. 2012. Waning protection after fifth dose of acellular pertussis vaccine in children. N. Engl. J. Med. 367:1012-1019. http://dx.doi.org/10.1056/ NEJMoa1200850.
12. Sheridan SL, Ware RS, Grimwood K, Lambert SB. 2012. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308:454-456. http://dx.doi.org/10.1001/jama.2012.6364.
13. Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. 2012. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 308:2126-2132. http://dx.doi.org/10.1001/ jama.2012.14939.
14. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, Diavatopoulos D, Teunis P, Nagelkerke N, Mertsola J. 2009. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg. Infect. Dis. 15:1206-1213. http://dx.doi.org/ 10.3201/eid1508.081511.
15. van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR. 2012. Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One 7:e46407. http://dx.doi.org/10.1371/ journal.pone.0046407.
16. Advani A, Gustafsson L, Ahrén C, Mooi FR, Hallander HO. 2011. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine 29:3438-3442. http://dx.doi.org/10.1016/j.vaccine.2011.02.070.
17. Hegerle N, Paris AS, Brun D, Dore G, Njamkepo E, Guillot S, Guiso N. 2012. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of bordetellae not expressing pertactin. Clin. Microbiol. Infect. 18:E340-E346. http://dx.doi.org/10.1111/j.1469-0691.2012.03925.x.
18. Kallonen T, Mertsola J, Mooi FR, He Q. 2012. Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR. Clin. Microbiol. Infect. 18:E377-E379. http://dx.doi.org/10.1111/j.1469-0691.2012.04000.x.
19. Lam C, Octavia S, Bahrame Z, Sintchenko V, Gilbert GL, Lan R. 2012. Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis. Infect. Genet. Evol. 12:492-495. http:// dx.doi.org/10.1016/j.meegid.2012.01.001.
20. Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, Lan R. 2012. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J. Infect. Dis. 205:1220-1224. http://dx.doi.org/10.1093/infdis/ jis178.
21. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L. 2012. Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg. Infect. Dis. 18:767-774. http://dx.doi.org/10.3201/ eid1805.110812.
22. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM. 2012. Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg. Infect. Dis. 18:1248-1255. http://dx.doi.org/ 10.3201/eid1808.120082.
23. Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. 2012. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin. Vaccine Immunol. 19:1703-1704. http:// dx.doi.org/10.1128/CVI.00367-12.
24. Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K, Kamachi K. 2012. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One 7:e31985. http://dx.doi.org/10.1371/journal.pone.0031985.
25. Queenan AM, Cassiday PK, Evangelista A. 2013. Pertactin-negative variants of Bordetella pertussis in the United States. N. Engl. J. Med. 368:-583-584. http://dx.doi.org/10.1056/NEJMc1209369.
26. Cummings CA, Bootsma HJ, Relman DA, Miller JF. 2006. Species-and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J. Bacteriol. 188:1775-1785. http://dx.doi.org/10.1128/JB.188.5.1775-1785.2006.
27. Streefland M, van de Waterbeemd B, Happé H, van der Pol LA, Beuvery EC, Tramper J, Martens DE. 2007. PAT for vaccines: the first stage of PAT implementation for development of a well-defined wholecell vaccine against whooping cough disease. Vaccine 25:2994-3000. http://dx.doi.org/10.1016/j.vaccine.2007.01.015.
28. Stibitz S. 2007. The bvg regulon, p 47-67. In Locht C (ed), Bordetella molecular microbiology. Horizon Bioscience, Norfolk, United Kingdom.
29. van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Kallonen T, He Q, Mertsola J, Advani A, Hallander HO, Janssens K, Hermans PW, Mooi FR. 2011. SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS One 6:e20340. http://dx.doi.org/10.1371/ journal.pone.0020340.
30. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, Holden MT, Churcher CM, Bentley SD, Mungall KL, Cerdeño-Tárraga AM, Temple L, James K, Harris B, Quail MA, Achtman M, Atkin R, Baker S, Basham D, Bason N, Cherevach I, Chillingworth T, Collins M, Cronin A, Davis P, Doggett J, Feltwell T, Goble A, Hamlin N, Hauser H, Holroyd S, Jagels K, Leather S, Moule S, Norberczak H, O'Neil S, Ormond D, Price C, Rabbinowitsch E, Rutter S, Sanders M, Saunders D, Seeger K, Sharp S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Unwin L, Whitehead S, Barrell BG, Maskell DJ. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35:32-40. http://dx.doi.org/10.1038/ng1227.
31. Moran NA, Plague GR. 2004. Genomic changes following host restriction in bacteria. Curr. Opin. Genet. Dev. 14:627-633. http://dx.doi.org/ 10.1016/j.gde.2004.09.003.
32. Litt DJ, Neal SE, Fry NK. 2009. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J. Clin. Microbiol. 47:680-688. http://dx.doi.org/10.1128/ JCM.01838-08.
33. Van Loo IH, Mooi FR. 2002. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 148:2011-2018.
34. Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. 2001. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39:4396-4403. http://dx.doi.org/ 10.1128/JCM.39.12.4396-4403.2001.
35. Berbers GA, de Greeff SC, Mooi FR. 2009. Improving pertussis vaccination. Hum. Vaccine 5:497-503.
36. Williamson P, Matthews R. 1996. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. FEMS Immunol. Med. Microbiol. 13:169-178. http://dx.doi.org/10.1111/j.1574-695X.1996.tb00231.x.
37. Packard ER, Parton R, Coote JG, Fry NK. 2004. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J. Med. Microbiol. 53:355-365. http://dx.doi.org/10.1099/ jmm.0.05515-0.
38. Octavia S, Maharjan RP, Sintchenko V, Stevenson G, Reeves PR, Gilbert GL, Lan R. 2011. Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol. Biol. Evol. 28:707-715. http://dx.doi.org/10.1093/molbev/msq245.
39. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. 1998. Polymorphism in the Bordetella pertussis virulence factors, p 69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66: 670-675.
40. Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernández J, Sisti F, Graieb A, Roberts R, Rico O, Ríos G, Regueira M, Binsztein N, Hozbor D. 2007. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin. Vaccine Immunol. 14: 1490-1498. http://dx.doi.org/10.1128/CVI.00177-07.
41. King AJ, Berbers G, van Oirschot HF, Hoogerhout P, Knipping K, Mooi FR. 2001. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 147:2885-2895.
42. Watanabe M, Nagai M. 2002. Effect of acellular pertussis vaccine against various strains of Bordetella pertussis in a murine model of respiratory infection. J. Health Sci. 48:560. http://dx.doi.org/10.1248/jhs.48.560.
43. Gzyl A, Augustynowicz E, Gniadek G, Rabczenko D, Dulny G, Slusarczyk J. 2004. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccineinduced immunity against currently circulating B. pertussis isolates. Vaccine 22:2122-2128. http://dx.doi.org/10.1016/j.vaccine.2003.12.006.
44. Komatsu E, Yamaguchi F, Abe A, Weiss AA, Watanabe M. 2010. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin. Vaccine Immunol. 17:807-812. http://dx.doi.org/ 10.1128/CVI.00449-09.
45. van Gent M, van Loo IH, Heuvelman KJ, de Neeling AJ, Teunis P, Mooi FR. 2011. Studies on Prn variation in the mouse model and comparison with epidemiological data. PLoS One 6:e18014. http://dx.doi.org/10.1371/ journal.pone.0018014.
46. Denoël P, Godfroid F, Guiso N, Hallander H, Poolman J. 2005. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine 23:5333-5341. http://dx.doi.org/10.1016/j.vaccine.2005.06.021.
47. Novichkov PS, Wolf YI, Dubchak I, Koonin EV. 2009. Trends in prokaryotic evolution revealed by comparison of closely related bacterial and archaeal genomes. J. Bacteriol. 191:65-73. http://dx.doi.org/10.1128/ JB.01237-08.
48. Rocha EP, Smith JM, Hurst LD, Holden MT, Cooper JE, Smith NH, Feil EJ. 2006. Comparisons of dN/dS are time dependent for closely related bacterial genomes. J. Theor. Biol. 239:226-235. http://dx.doi.org/ 10.1016/j.jtbi.2005.08.037.
49. Yang Z, Bielawski JP. 2000. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15:496-503. http://dx.doi.org/10.1016/ S0169-5347(00)01994-7.
50. Kudla G, Murray AW, Tollervey D, Plotkin JB. 2009. Coding-sequence determinants of gene expression in Escherichia coli. Science 324:255-258. http://dx.doi.org/10.1126/science.1170160.
51. Locht C, Coutte L, Mielcarek N. 2011. The ins and outs of pertussis toxin. FEBS J. 278:4668-4682. http://dx.doi.org/10.1111/j.1742-4658.2011.08237.x.
52. Imperi F, Tiburzi F, Fimia GM, Visca P. 2010. Transcriptional control of the pvdS iron starvation sigma factor gene by the master regulator of sulfur metabolism CysB in Pseudomonas aeruginosa. Environ. Microbiol. 12: 1630-1642. doi: 10.1111/j.1462-2920.2010.02210.x.
53. Kredich NM. 1992. The molecular basis for positive regulation of cys promoters in Salmonella typhimurium and Escherichia coli. Mol. Microbiol. 6:2747-2753. http://dx.doi.org/10.1111/j.1365-2958.1992.tb01453.x.
54. Boucher PE, Maris AE, Yang MS, Stibitz S. 2003. The response regulator BvgA and RNA polymerase alpha subunit C-terminal domain bind simultaneously to different faces of the same segment of promoter DNA. Mol. Cell 11:163-173. http://dx.doi.org/10.1016/S1097-2765(03)00007-8.
55. Boucher PE, Murakami K, Ishihama A, Stibitz S. 1997. Nature of DNA binding and RNA polymerase interaction of the Bordetella pertussis BvgA transcriptional activator at the fha promoter. J. Bacteriol. 179:1755-1763.
56. Boucher PE, Yang MS, Schmidt DM, Stibitz S. 2001. Genetic and biochemical analyses of BvgA interaction with the secondary binding region of the fha promoter of Bordetella pertussis. J. Bacteriol. 183:536-544. http://dx.doi.org/10.1128/JB.183.2.536-544.2001.
57. Boucher PE, Yang MS, Stibitz S. 2001. Mutational analysis of the highaffinity BvgA binding site in the fha promoter of Bordetella pertussis. Mol. Microbiol. 40:991-999. http://dx.doi.org/10.1046/j.1365-2958.2001.02442.x.
58. Decker KB, Chen Q, Hsieh ML, Boucher P, Stibitz S, Hinton DM. 2011. Different requirements for _ region 4 in BvgA activation of the Bordetella pertussis promoters P(fim3) and P(fhaB). J. Mol. Biol. 409:692-709. http://dx.doi.org/10.1016/j.jmb.2011.04.017.
59. Mattoo S, Miller JF, Cotter PA. 2000. Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect. Immun. 68:2024-2033. http://dx.doi.org/10.1128/ IAI.68.4.2024-2033.2000.
60. Łochowska A, Iwanicka-Nowicka R, Zielak A, Modelewska A, Thomas MS, Hryniewicz MM. 2011. Regulation of sulfur assimilation pathways in Burkholderia cenocepacia through control of genes by the SsuR transcription factor. J. Bacteriol. 193:1843-1853. http://dx.doi.org/10.1128/ JB.00483-10.
61. Achtman M. 2012. Insights from genomic comparisons of genetically monomorphic bacterial pathogens. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367:860-867. http://dx.doi.org/10.1098/rstb.2011.0303.
62. Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, Relman DA. 2006. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J. Bacteriol. 188:2375-2382. http://dx.doi.org/10.1128/JB.188.7.2375-2382.2006.
63. Caro V, Bouchez V, Guiso N. 2008. Is the sequenced Bordetella pertussis strain Tohama I representative of the species? J. Clin. Microbiol. 46: 2125-2128. http://dx.doi.org/10.1128/JCM.02484-07.
64. Bouchez V, Caro V, Levillain E, Guigon G, Guiso N. 2008. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS One 3:e2437. http://dx.doi.org/10.1371/ journal.pone.0002437.
65. King AJ, van Gorkom T, van der Heide HG, Advani A, van der Lee S. 2010. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC Genomics 11:64. http://dx.doi.org/10.1186/ 1471-2164-11-64.
66. Bart MJ, van Gent M, van der Heide HG, Boekhorst J, Hermans P, Parkhill J, Mooi FR. 2010. Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics 11:627. http:// dx.doi.org/10.1186/1471-2164-11-627.
67. Bogdan JA, Nazario-Larrieu J, Sarwar J, Alexander P, Blake MS. 2001. Bordetella pertussis autoregulates pertussis toxin production through the metabolism of cysteine. Infect. Immun. 69:6823-6830. http://dx.doi.org/ 10.1128/IAI.69.11.6823-6830.2001.
68. Njamkepo E, Cantinelli T, Guigon G, Guiso N. 2008. Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. Microbes Infect. 10:1582-1586. http://dx.doi.org/ 10.1016/j.micinf.2008.09.012.
69. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J, Carter RJ, Keira Cheetham R, Cox AJ, Ellis DJ, Flatbush MR, Gormley NA, Humphray SJ, Irving LJ, Karbelashvili MS, Kirk SM, Li H, Liu X, Maisinger KS, Murray LJ, Obradovic B, Ost T, Parkinson ML, Pratt MR, Rasolonjatovo IM, Reed MT, Rigatti R, Rodighiero C, Ross MT, Sabot A, Sankar SV, Scally A, Schroth GP, Smith ME, Smith VP, Spiridou A, Torrance PE, Tzonev SS, Vermaas EH, Walter K, Wu X, Zhang L, Alam MD, Anastasi C, et al. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456: 53-59. http://dx.doi.org/10.1038/nature07517.
70. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. 2009. Pindel: a pattern growth approach to detect breakpoints of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25: 2865-2871. http://dx.doi.org/10.1093/bioinformatics/btp394.
71. Albers CA, Lunter G, MacArthur DG, McVean G, Ouwehand WH, Durbin R. 2011. Dindel: accurate indel calls from short-read data. Genome Res. 21:961-973. http://dx.doi.org/10.1101/gr.112326.110.
72. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, Gardete S, Tavares A, Day N, Lindsay JA, Edgeworth JD, de Lencastre H, Parkhill J, Peacock SJ, Bentley SD. 2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327: 469-474. http://dx.doi.org/10.1126/science.1182395.
73. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410. http://dx.doi.org/ 10.1016/S0022-2836(05)80360-2.
74. Schultz J, Milpetz F, Bork P, Ponting CP. 1998. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl. Acad. Sci. U. S. A. 95:5857-5864.
75. Marchler-Bauer A, Zheng C, Chitsaz F, Derbyshire MK, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Lanczycki CJ, Lu F, Lu S, Marchler GH, Song JS, Thanki N, Yamashita RA, Zhang D, Bryant SH. 2013. CDD: conserved domains and protein three-dimensional structure. Nucleic Acids Res. 41:D348-D352. http://dx.doi.org/10.1093/nar/gks1243.
76. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52: 696-704. http://dx.doi.org/10.1080/10635150390235520.
77. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. 2005. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog. 1:e45. http://dx.doi.org/10.1371/ journal.ppat.0010045.
78. Park J, Zhang Y, Buboltz AM, Zhang X, Schuster SC, Ahuja U, Liu M, Miller JF, Sebaihia M, Bentley SD, Parkhill J, Harvill ET. 2012. Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. BMC Genomics 13:545. http://dx.doi.org/10.1186/1471-2164-13-545.
79. Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST. Mol. Biol. Evol. 29:1969-1973. http://dx.doi.org/10.1093/molbev/mss075.
80. Yu NY, Laird MR, Spencer C, Brinkman FS. 2011. PSORTdb-an expanded, auto-updated, user-friendly protein subcellular localization database for Bacteria and Archaea. Nucleic Acids Res. 39:D241-D244. http://dx.doi.org/10.1093/nar/gkq1093.
81. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Stat. Methodol. 57:289-300.